XML 42 R31.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 | Dec. 31, 2022
--- | --- | --- | --- | ---
Investments at cost | $ 765,173 | $ 759,182 |  |
Investments at fair value | 711,116 | 709,085 |  |
Warrant [Member] |  |  |  |
Investments at cost | 16,636 | 16,526 |  |
Investments at fair value | 23,928 | 24,594 |  |
Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost | 721,456 | 716,077 |  |
Investments at fair value | 684,895 | 693,730 |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | 690,431 | 692,345 |  |
Investments at fair value | 653,053 | 664,203 |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost | 16,511 | 16,400 |  |
Investments at fair value | 23,928 | 24,594 |  |
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |  |  |
Investments at cost | 6,133 | 6,132 |  |
Investments at fair value | 4,567 | 4,733 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost | 28,689 | 28,677 |  |
Investments at fair value | 12,577 | 1,132 | $ 846 | $ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member] |  |  |  |
Investments at fair value | 12,577 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member] |  |  |  |
Investments at cost | 125 | 126 |  |
Investments at fair value | 0 | 0 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] |  |  |  |
Investments at fair value | 0 | 0 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member] |  |  |  |
Investments at fair value |  |  | $ 846 | $ 0
Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost | 15,028 | 14,428 |  |
Investments at fair value | 13,644 | 14,223 |  |
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] |  |  |  |
Investments at fair value | 5,845 | 6,230 |  |
Biotechnology Sector [Member] |  |  |  |
Investments at cost | 142,108 | 145,544 |  |
Investments at fair value | $ 124,741 | $ 117,781 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 9.55% | 9.55% |  |
Ceiling | 13.50% | 13.50% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,982 | 4,979 |  |
Investments at fair value | $ 4,982 | $ 4,979 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 9.55% | 9.55% |  |
Ceiling | 13.50% | 13.50% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,982 | 4,979 |  |
Investments at fair value | 4,982 | 4,979 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 214 | 214 |  |
Investments at fair value | $ 220 | $ 318 |  |
Number of Shares (in shares) | 7,404 | 7,404 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 250 | $ 250 |  |
Investments at fair value | $ 250 | $ 250 |  |
Number of Shares (in shares) | 1,162 | 1,162 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 9.55% | 9.55% |  |
Ceiling | 13.50% | 13.50% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 3,000 | $ 3,000 |  |
Investments at cost | 2,989 | 2,987 |  |
Investments at fair value | $ 2,989 | $ 2,987 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 9.55% | 9.55% |  |
Ceiling | 13.50% | 13.50% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,982 | 4,979 |  |
Investments at fair value | $ 4,982 | $ 4,979 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 9.55% | 9.55% |  |
Ceiling | 13.50% | 13.50% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,982 | 4,979 |  |
Investments at fair value | $ 4,982 | $ 4,979 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 9.55% | 9.55% |  |
Ceiling | 13.50% | 13.50% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 3,000 | $ 3,000 |  |
Investments at cost | 2,989 | 2,987 |  |
Investments at fair value | 2,989 | 2,987 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 311 | 311 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 117 | 117 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.22% | 13.22% |  |
Margin | 4.72% | 4.72% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jun. 01, 2024 | Jun. 01, 2024 |  |
Principal Amount | $ 565 | $ 1,414 |  |
Investments at cost | 564 | 1,410 |  |
Investments at fair value | $ 564 | $ 1,410 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.22% | 13.22% |  |
Margin | 4.72% | 4.72% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jun. 01, 2024 | Jun. 01, 2024 |  |
Principal Amount | $ 565 | $ 1,414 |  |
Investments at cost | 564 | 1,410 |  |
Investments at fair value | 564 | 1,410 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 176 | 178 |  |
Investments at fair value | $ 135 | $ 246 |  |
Number of Shares (in shares) | 110,402 | 110,402 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 355 | $ 355 |  |
Investments at fair value | $ 355 | $ 355 |  |
Number of Shares (in shares) | 32,831 | 32,831 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 13.22% | 13.22% |  |
Margin | 4.72% | 4.72% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Nov. 01, 2025 | Nov. 01, 2025 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,957 | 4,950 |  |
Investments at fair value | $ 4,957 | $ 4,950 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 13.22% | 13.22% |  |
Margin | 4.72% | 4.72% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,958 | 4,949 |  |
Investments at fair value | 4,958 | 4,949 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Imunon, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 65 | 65 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 19,671 | 19,671 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | May 01, 2027 | May 01, 2027 |  |
Principal Amount | $ 6,250 | $ 6,250 |  |
Investments at cost | 6,204 | 6,199 |  |
Investments at fair value | $ 6,204 | $ 6,199 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | May 01, 2027 | May 01, 2027 |  |
Principal Amount | $ 6,250 | $ 6,250 |  |
Investments at cost | 6,204 | 6,199 |  |
Investments at fair value | 6,204 | 6,199 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 50 | 50 |  |
Investments at fair value | $ 54 | $ 53 |  |
Number of Shares (in shares) | 48,076 | 48,076 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mustang Bio, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 146 | $ 146 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 16,611 | 16,611 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.75% | 13.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Nov. 01, 2026 | Nov. 01, 2026 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,725 | 3,716 |  |
Investments at fair value | $ 3,725 | $ 3,716 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.75% | 13.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Nov. 01, 2026 | Nov. 01, 2026 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,484 | 2,478 |  |
Investments at fair value | 2,484 | 2,478 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 64 | 64 |  |
Investments at fair value | $ 80 | $ 157 |  |
Number of Shares (in shares) | 103,679 | 103,679 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.75% | 3.75% |  |
Maturity Date | Sep. 01, 2026 | Sep. 01, 2026 |  |
Principal Amount | $ 10,000 | $ 10,000 |  |
Investments at cost | 9,924 | 9,911 |  |
Investments at fair value | $ 9,924 | $ 9,911 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.75% | 3.75% |  |
Maturity Date | Sep. 01, 2026 | Sep. 01, 2026 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,722 | 3,717 |  |
Investments at fair value | 3,722 | 3,717 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 160 | 160 |  |
Investments at fair value | $ 364 | $ 606 |  |
Number of Shares (in shares) | 299,848 | 299,848 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.75% | 3.75% |  |
Maturity Date | Sep. 01, 2026 | Sep. 01, 2026 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,722 | 3,717 |  |
Investments at fair value | $ 3,722 | $ 3,717 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.86% | 13.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024 |  |
Principal Amount | $ 4,667 | $ 4,666 |  |
Investments at cost | 4,603 | 4,579 |  |
Investments at fair value | $ 4,327 | $ 4,414 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.86% | 13.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024 |  |
Principal Amount | $ 4,667 | $ 4,666 |  |
Investments at cost | 4,603 | 4,579 |  |
Investments at fair value | 4,327 | 4,414 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 278 | 278 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 175,098 | 175,098 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 312 | $ 312 |  |
Investments at fair value | $ 232 | $ 225 |  |
Number of Shares (in shares) | 691,895 | 691,895 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 13.86% | 13.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024 |  |
Principal Amount | $ 2,333 | $ 2,333 |  |
Investments at cost | 2,295 | 2,281 |  |
Investments at fair value | $ 2,158 | $ 2,199 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 13.86% | 13.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024 |  |
Principal Amount | $ 2,333 | $ 2,333 |  |
Investments at cost | 2,295 | 2,281 |  |
Investments at fair value | $ 2,158 | $ 2,199 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 13.86% | 13.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024 |  |
Principal Amount | $ 2,333 | $ 2,333 |  |
Investments at cost | 2,293 | 2,278 |  |
Investments at fair value | $ 2,156 | $ 2,196 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 13.86% | 13.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024 |  |
Principal Amount | $ 2,333 | $ 2,333 |  |
Investments at cost | 2,293 | 2,278 |  |
Investments at fair value | $ 2,156 | $ 2,196 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025 |  |
Principal Amount | $ 2,500 | $ 3,000 |  |
Investments at cost | 2,429 | 2,914 |  |
Investments at fair value | $ 2,429 | $ 2,870 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025 |  |
Principal Amount | $ 1,250 | $ 1,500 |  |
Investments at cost | 1,215 | 1,458 |  |
Investments at fair value | $ 1,215 | $ 1,436 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 8.75% | 8.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 6.00% | 6.00% |  |
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025 |  |
Principal Amount | $ 3,643 | $ 4,250 |  |
Investments at cost | 3,594 | 4,193 |  |
Investments at fair value | $ 3,594 | $ 4,193 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 8.75% | 8.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 6.00% | 6.00% |  |
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025 |  |
Principal Amount | $ 1,821 | $ 2,125 |  |
Investments at cost | 1,797 | 2,096 |  |
Investments at fair value | 1,797 | 2,096 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 264 | 264 |  |
Investments at fair value | $ 116 | $ 113 |  |
Number of Shares (in shares) | 318,181 | 318,181 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,232 | 2,230 |  |
Investments at fair value | $ 2,232 | $ 2,230 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,462 | 2,459 |  |
Investments at fair value | 2,462 | 2,459 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 194 | 194 |  |
Investments at fair value | $ 175 | $ 172 |  |
Number of Shares (in shares) | 1,600,002 | 1,600,002 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Xeris Pharmaceuticals, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 72 | $ 72 |  |
Investments at fair value | $ 26 | $ 33 |  |
Number of Shares (in shares) | 126,000 | 126,000 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cadrenal Therapeutics, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 0 | $ 0 |  |
Investments at fair value | $ 367 | $ 443 |  |
Number of Shares (in shares) | 600,000 | 600,000 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Warrant [Member] |  |  |  |
Investments at cost | $ 125 | $ 126 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 23,196 | 23,196 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.25% | 2.27% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 5,712 | $ 5,532 |  |
Investments at cost | 5,228 | 5,228 |  |
Investments at fair value | $ 2,790 | $ 222 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.25% | 2.27% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 8,568 | $ 8,298 |  |
Investments at cost | 7,880 | 7,867 |  |
Investments at fair value | 4,207 | 336 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 5,000 | 5,000 |  |
Investments at fair value | $ 0 | $ 132 |  |
Number of Shares (in shares) | 2,164,502 | 2,164,502 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.25% | 2.27% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 3,427 | $ 3,319 |  |
Investments at cost | 3,137 | 3,137 |  |
Investments at fair value | $ 1,674 | $ 133 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.25% | 2.27% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 3,427 | $ 3,319 |  |
Investments at cost | 3,137 | 3,137 |  |
Investments at fair value | $ 1,674 | $ 133 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.25% | 2.27% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 2,285 | $ 2,213 |  |
Investments at cost | 2,091 | 2,091 |  |
Investments at fair value | $ 1,116 | $ 88 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.25% | 2.27% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 2,285 | $ 2,213 |  |
Investments at cost | 2,091 | 2,091 |  |
Investments at fair value | 1,116 | 88 |  |
Medical Device Sector [Member] |  |  |  |
Investments at cost | 164,060 | 147,064 |  |
Investments at fair value | $ 161,155 | $ 145,019 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,726 | 3,722 |  |
Investments at fair value | $ 3,726 | $ 3,722 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,725 | 3,722 |  |
Investments at fair value | 3,725 | 3,722 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 103 | 103 |  |
Investments at fair value | $ 329 | $ 215 |  |
Number of Shares (in shares) | 34,410 | 34,410 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 13.75% | 13.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,949 | 4,943 |  |
Investments at fair value | $ 4,949 | $ 4,943 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 13.75% | 13.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,909 | 4,900 |  |
Investments at fair value | 4,909 | $ 4,900 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Nov. 01, 2026 |  |
Principal Amount |  | $ 3,500 |  |
Investments at cost |  | 3,469 |  |
Investments at fair value |  | $ 1,574 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Nov. 01, 2026 |  |
Principal Amount |  | $ 3,500 |  |
Investments at cost |  | 3,563 |  |
Investments at fair value |  | $ 1,617 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost | 7,181 |  |  |
Investments at fair value | $ 3,247 |  |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,475 | 2,297 |  |
Investments at fair value | $ 2,475 | $ 2,297 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,475 | 2,473 |  |
Investments at fair value | 2,475 | 2,473 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 275 | 275 |  |
Investments at fair value | $ 276 | $ 269 |  |
Number of Shares (in shares) | 2,637,041 | 2,637,043 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,950 | 4,946 |  |
Investments at fair value | $ 4,950 | $ 4,946 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,950 | 4,946 |  |
Investments at fair value | $ 4,950 | $ 4,946 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 12.00% |  |  |
Margin | 3.50% |  |  |
Floor | 11.75% |  |  |
Ceiling | 0.00% |  |  |
ETP | 8.00% |  |  |
Maturity Date | Apr. 01, 2028 |  |  |
Principal Amount | $ 3,750 |  |  |
Investments at cost | 3,706 |  |  |
Investments at fair value | $ 3,706 |  |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 12.00% |  |  |
Margin | 3.50% |  |  |
Floor | 11.75% |  |  |
Ceiling | 0.00% |  |  |
ETP | 8.00% |  |  |
Maturity Date | Apr. 01, 2028 |  |  |
Principal Amount | $ 3,750 |  |  |
Investments at cost | 3,706 |  |  |
Investments at fair value | $ 3,706 |  |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate | 12.00% |  |  |
Margin | 3.50% |  |  |
Floor | 11.75% |  |  |
Ceiling | 0.00% |  |  |
ETP | 8.00% |  |  |
Maturity Date | Apr. 01, 2028 |  |  |
Principal Amount | $ 3,750 |  |  |
Investments at cost | 3,706 |  |  |
Investments at fair value | $ 3,706 |  |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate | 12.00% |  |  |
Margin | 3.50% |  |  |
Floor | 11.75% |  |  |
Ceiling | 0.00% |  |  |
ETP | 8.00% |  |  |
Maturity Date | Apr. 01, 2028 |  |  |
Principal Amount | $ 3,750 |  |  |
Investments at cost | 3,706 |  |  |
Investments at fair value | $ 3,706 |  |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 1.00% | 1.00% |  |
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,981 | 4,978 |  |
Investments at fair value | $ 4,981 | $ 4,978 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 1.00% | 1.00% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,491 | 2,489 |  |
Investments at fair value | 2,491 | 2,489 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 2,000 | 2,000 |  |
Investments at fair value | $ 1,700 | $ 1,700 |  |
Number of Shares (in shares) | 392,651 | 392,651 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost | $ 1,200 | $ 1,200 |  |
Investments at fair value | $ 100 | $ 200 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.75% | 13.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 3,500 | $ 3,500 |  |
Investments at cost | 3,470 | 3,467 |  |
Investments at fair value | $ 3,470 | $ 3,467 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.75% | 13.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 3,500 | $ 3,500 |  |
Investments at cost | 3,470 | 3,467 |  |
Investments at fair value | 3,470 | 3,467 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 71 | 71 |  |
Investments at fair value | $ 2 | $ 1 |  |
Number of Shares (in shares) | 135,484 | 135,484 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 13.75% | 13.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 3,500 | $ 3,500 |  |
Investments at cost | 3,459 | 3,456 |  |
Investments at fair value | $ 3,459 | $ 3,456 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 13.75% | 13.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 3,500 | $ 3,500 |  |
Investments at cost | 3,459 | 3,456 |  |
Investments at fair value | 3,459 | 3,456 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | ZetrOZ, Inc [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost | 0 | 0 |  |
Investments at fair value | 0 | 0 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | AccuVein Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 7 | 24 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 271 | 1,175 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerin Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 66 | $ 66 |  |
Investments at fair value | $ 1,046 | $ 1,199 |  |
Number of Shares (in shares) | 1,818,183 | 1,818,183 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 48 | $ 48 |  |
Investments at fair value | $ 10 | $ 9 |  |
Number of Shares (in shares) | 8,800 | 8,800 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index One [Member] |  |  |  |
Cash Rate | 9.00% | 9.00% |  |
Margin | 0.00% | 0.00% |  |
Floor | 0.00% | 0.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 18.00% | 18.00% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,471 | 2,468 |  |
Investments at fair value | $ 2,339 | $ 2,342 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |
Cash Rate | 9.00% | 9.00% |  |
Margin | 0.00% | 0.00% |  |
Floor | 0.00% | 0.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 18.00% | 18.00% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,471 | 2,468 |  |
Investments at fair value | $ 2,339 | $ 2,342 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Three [Member] |  |  |  |
Cash Rate | 9.00% | 9.00% |  |
Margin | 0.00% | 0.00% |  |
Floor | 0.00% | 0.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 18.00% | 18.00% |  |
Maturity Date | Jun. 30, 2024 | Jun. 30, 2024 |  |
Principal Amount | $ 200 | $ 200 |  |
Investments at cost | 200 | 200 |  |
Investments at fair value | $ 189 | $ 190 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 15,000 | $ 15,000 |  |
Investments at cost | 14,690 | 14,675 |  |
Investments at fair value | $ 14,690 | $ 14,675 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 10,000 | $ 10,000 |  |
Investments at cost | 9,793 | 9,784 |  |
Investments at fair value | 9,793 | 9,784 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 432 | 432 |  |
Investments at fair value | $ 368 | $ 379 |  |
Number of Shares (in shares) | 4,109 | 4,109 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,897 | 4,892 |  |
Investments at fair value | $ 4,897 | $ 4,892 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,449 | 2,446 |  |
Investments at fair value | 2,449 | 2,446 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 86 | 86 |  |
Investments at fair value | $ 1,299 | $ 1,305 |  |
Number of Shares (in shares) | 12,153 | 12,153 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.50% | 11.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,764 | 4,757 |  |
Investments at fair value | $ 4,764 | $ 4,757 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.50% | 11.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,457 | 2,454 |  |
Investments at fair value | 2,457 | 2,454 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 152 | 152 |  |
Investments at fair value | $ 138 | $ 135 |  |
Number of Shares (in shares) | 93,336 | 93,336 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.50% | 11.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,457 | 2,454 |  |
Investments at fair value | $ 2,457 | $ 2,454 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.25% | 12.00% |  |
Margin | 2.75% | 3.50% |  |
Floor | 9.25% | 8.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 5.50% |  |
Maturity Date | Mar. 01, 2029 | Oct. 01, 2024 |  |
Principal Amount | $ 5,000 | $ 3,750 |  |
Investments at cost | 4,811 | 3,738 |  |
Investments at fair value | $ 4,811 | $ 3,738 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 11.25% | 12.00% |  |
Margin | 2.75% | 3.50% |  |
Floor | 9.25% | 8.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 5.50% |  |
Maturity Date | Mar. 01, 2029 | Oct. 01, 2024 |  |
Principal Amount | $ 5,000 | $ 3,750 |  |
Investments at cost | 4,932 | 3,738 |  |
Investments at fair value | 4,932 | 3,738 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 139 | 69 |  |
Investments at fair value | $ 267 | $ 229 |  |
Number of Shares (in shares) | 219,866 | 145,483 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 11.25% | 12.00% |  |
Margin | 2.75% | 3.50% |  |
Floor | 9.25% | 8.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 5.50% |  |
Maturity Date | Mar. 01, 2029 | Oct. 01, 2024 |  |
Principal Amount | $ 4,000 | $ 1,875 |  |
Investments at cost | 3,946 | 1,866 |  |
Investments at fair value | 3,946 | $ 1,866 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 8.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.50% |  |
Maturity Date |  | Oct. 01, 2024 |  |
Principal Amount |  | $ 1,875 |  |
Investments at cost |  | 1,866 |  |
Investments at fair value |  | $ 1,866 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] |  |  |  |
Investments at cost | 162 |  |  |
Investments at fair value | $ 182 |  |  |
Number of Shares (in shares) | 4,635,992 |  |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 8.75% | 8.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 6.00% | 6.00% |  |
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026 |  |
Principal Amount | $ 4,375 | $ 4,583 |  |
Investments at cost | 4,332 | 4,546 |  |
Investments at fair value | $ 4,332 | $ 4,546 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 8.75% | 8.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 6.00% | 6.00% |  |
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026 |  |
Principal Amount | $ 2,188 | $ 2,292 |  |
Investments at cost | 2,166 | 2,273 |  |
Investments at fair value | 2,166 | 2,273 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 0 |  |  |
Investments at fair value | $ 0 |  |  |
Number of Shares (in shares) | 30,585 |  |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 149 |  |
Investments at fair value |  | $ 167 |  |
Number of Shares (in shares) |  | 4,106,174 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.32% | 13.32% |  |
Margin | 4.82% | 4.82% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 10.36% | 10.36% |  |
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025 |  |
Principal Amount | $ 3,911 | $ 3,960 |  |
Investments at cost | 3,864 | 3,923 |  |
Investments at fair value | $ 3,864 | $ 3,923 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.32% | 13.32% |  |
Margin | 4.82% | 4.82% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 10.36% | 10.36% |  |
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025 |  |
Principal Amount | $ 3,911 | $ 3,960 |  |
Investments at cost | 3,864 | 3,923 |  |
Investments at fair value | 3,864 | 3,923 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 256 | 221 |  |
Investments at fair value | $ 247 | $ 206 |  |
Number of Shares (in shares) | 9,313,541 | 7,972,222 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.59% | 13.59% |  |
Margin | 5.09% | 5.09% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2024 | Jan. 01, 2024 |  |
Principal Amount | $ 391 | $ 500 |  |
Investments at cost | 391 | 500 |  |
Investments at fair value | $ 391 | $ 500 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.59% | 13.59% |  |
Margin | 5.09% | 5.09% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Mar. 01, 2024 | Jan. 01, 2024 |  |
Principal Amount | $ 533 | $ 33 |  |
Investments at cost | 533 | 33 |  |
Investments at fair value | 533 | 33 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 174 | 174 |  |
Investments at fair value | $ 128 | $ 124 |  |
Number of Shares (in shares) | 3,341,376 | 3,341,376 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 13.59% |  |
Margin |  | 5.09% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Mar. 01, 2024 |  |
Principal Amount |  | $ 800 |  |
Investments at cost |  | 794 |  |
Investments at fair value |  | 794 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CVRx, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 76 | 76 |  |
Investments at fair value | $ 382 | $ 980 |  |
Number of Shares (in shares) | 47,410 | 47,410 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 124 | $ 124 |  |
Investments at fair value | $ 50 | $ 26 |  |
Number of Shares (in shares) | 2,010,424 | 2,010,424 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 195 | $ 194 |  |
Investments at fair value | $ 374 | $ 368 |  |
Number of Shares (in shares) | 809,931 | 809,931 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Meditrina, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 83 | $ 83 |  |
Investments at fair value | $ 54 | $ 93 |  |
Number of Shares (in shares) | 233,993 | 233,993 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,691 | 3,689 |  |
Investments at fair value | $ 3,691 | $ 3,689 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,691 | 3,689 |  |
Investments at fair value | 3,691 | 3,689 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | MicroTransponder, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 47 | 47 |  |
Investments at fair value | $ 48 | $ 47 |  |
Number of Shares (in shares) | 103,172 | 103,172 |  |
Medical Device Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 0 | $ 0 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 660,537 | 660,537 |  |
Communications Sector [Member] |  |  |  |
Investments at cost | $ 17,327 | $ 19,192 |  |
Investments at fair value | $ 20,185 | $ 22,188 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 5,625 | $ 6,250 |  |
Investments at cost | 5,597 | 6,218 |  |
Investments at fair value | $ 5,597 | $ 6,218 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 5,625 | $ 6,250 |  |
Investments at cost | 5,597 | 6,218 |  |
Investments at fair value | 5,597 | 6,218 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 46 | 47 |  |
Investments at fair value | $ 62 | $ 61 |  |
Number of Shares (in shares) | 1,991 | 1,991 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 5,625 | $ 6,250 |  |
Investments at cost | 5,597 | 6,218 |  |
Investments at fair value | 5,597 | 6,218 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | 261 | 261 |  |
Investments at fair value | $ 306 | $ 306 |  |
Number of Shares (in shares) | 1,810 | 1,810 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Intelepeer Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 137 | $ 138 |  |
Investments at fair value | $ 2,894 | $ 3,036 |  |
Number of Shares (in shares) | 2,936,535 | 2,936,535 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | PebblePost, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 92 | $ 92 |  |
Investments at fair value | $ 132 | $ 131 |  |
Number of Shares (in shares) | 598,850 | 598,850 |  |
Software Sector [Member] |  |  |  |
Investments at cost | $ 159,094 | $ 164,133 |  |
Investments at fair value | $ 154,908 | $ 160,749 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.00% | 15.00% |  |
Margin | 6.50% | 6.50% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 6,701 | $ 6,625 |  |
Investments at cost | 6,607 | 6,519 |  |
Investments at fair value | $ 6,303 | $ 6,176 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 15.00% | 15.00% |  |
Margin | 6.50% | 6.50% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 6,185 | $ 6,116 |  |
Investments at cost | 6,098 | 6,018 |  |
Investments at fair value | 5,819 | 5,701 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 455 | 455 |  |
Investments at fair value | $ 56 | $ 46 |  |
Number of Shares (in shares) | 516,732 | 516,732 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 15.00% | 15.00% |  |
Margin | 6.50% | 6.50% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026 |  |
Principal Amount | $ 2,577 | $ 2,548 |  |
Investments at cost | 2,541 | 2,507 |  |
Investments at fair value | $ 2,425 | $ 2,375 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 10,000 | $ 10,000 |  |
Investments at cost | 9,912 | 9,895 |  |
Investments at fair value | $ 9,540 | $ 9,895 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 10,000 | $ 10,000 |  |
Investments at cost | 9,912 | 9,895 |  |
Investments at fair value | 9,540 | 9,895 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 273 | 273 |  |
Investments at fair value | $ 11 | $ 13 |  |
Number of Shares (in shares) | 639,918 | 639,918 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,956 | 4,947 |  |
Investments at fair value | $ 4,770 | $ 4,947 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,956 | 4,947 |  |
Investments at fair value | 4,770 | $ 4,947 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.75% |  |
Margin |  | 6.25% |  |
Floor |  | 9.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.50% |  |
Maturity Date |  | Jul. 01, 2027 |  |
Principal Amount |  | $ 3,750 |  |
Investments at cost |  | 3,728 |  |
Investments at fair value |  | $ 3,728 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.75% |  |
Margin |  | 6.25% |  |
Floor |  | 9.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.50% |  |
Maturity Date |  | Jul. 01, 2027 |  |
Principal Amount |  | $ 3,750 |  |
Investments at cost |  | 3,728 |  |
Investments at fair value |  | 3,728 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 168 | 167 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 85,066 | 85,066 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 191 | $ 192 |  |
Investments at fair value | $ 98 | $ 99 |  |
Number of Shares (in shares) | 652,250 | 652,250 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.00% | 15.00% |  |
Margin | 6.50% | 6.50% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Mar. 01, 2026 | Mar. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,977 | 4,971 |  |
Investments at fair value | $ 4,977 | $ 4,971 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 15.00% | 15.00% |  |
Margin | 6.50% | 6.50% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Mar. 01, 2026 | Mar. 01, 2026 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,489 | 2,486 |  |
Investments at fair value | 2,489 | 2,486 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 34 | 32 |  |
Investments at fair value | $ 121 | $ 120 |  |
Number of Shares (in shares) | 101,308 | 101,308 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Medsphere Systems Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 60 | $ 60 |  |
Investments at fair value | $ 134 | $ 108 |  |
Number of Shares (in shares) | 7,097,792 | 7,097,792 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 163 | $ 163 |  |
Investments at fair value | $ 58 | $ 50 |  |
Number of Shares (in shares) | 150,353 | 150,353 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 14.25% | 14.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 4.00% |  |
Maturity Date | Nov. 01, 2026 | Nov. 01, 2026 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,473 | 2,471 |  |
Investments at fair value | $ 2,473 | $ 2,373 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 14.25% | 14.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 4.00% |  |
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026 |  |
Principal Amount | $ 1,250 | $ 1,250 |  |
Investments at cost | 1,239 | 1,237 |  |
Investments at fair value | 1,239 | 1,188 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 43 | 43 |  |
Investments at fair value | $ 0 | $ 1 |  |
Number of Shares (in shares) | 85,543 | 85,543 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 14.25% | 14.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 4.00% |  |
Maturity Date | Apr. 01, 2027 | Apr. 01, 2027 |  |
Principal Amount | $ 1,000 | $ 1,000 |  |
Investments at cost | 994 | 994 |  |
Investments at fair value | $ 994 | $ 954 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,783 | 4,779 |  |
Investments at fair value | $ 4,783 | $ 4,779 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,919 | 4,915 |  |
Investments at fair value | 4,919 | 4,915 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 220 | 223 |  |
Investments at fair value | $ 253 | $ 247 |  |
Number of Shares (in shares) | 948,275 | 948,275 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,919 | 4,915 |  |
Investments at fair value | $ 4,919 | $ 4,915 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,919 | 4,915 |  |
Investments at fair value | $ 4,919 | $ 4,915 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027 |  |
Principal Amount | $ 10,000 | $ 10,000 |  |
Investments at cost | 9,896 | 9,885 |  |
Investments at fair value | $ 9,896 | $ 9,885 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,947 | 4,942 |  |
Investments at fair value | 4,947 | 4,942 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 116 | 115 |  |
Investments at fair value | $ 3 | $ 2 |  |
Number of Shares (in shares) | 84,037 | 84,037 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date |  | Mar. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,947 | 4,942 |  |
Investments at fair value | $ 4,947 | $ 4,942 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.75% | 15.75% |  |
Margin | 7.25% | 7.25% |  |
Floor | 10.50% | 10.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025 |  |
Principal Amount | $ 3,233 | $ 3,667 |  |
Investments at cost | 3,182 | 3,625 |  |
Investments at fair value | 3,182 | 3,625 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 66 | 56 |  |
Investments at fair value | $ 83 | $ 80 |  |
Number of Shares (in shares) | 4,104 | 3,731 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,965 | 4,959 |  |
Investments at fair value | $ 4,965 | $ 4,959 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,965 | 4,959 |  |
Investments at fair value | 4,965 | 4,959 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 123 | 123 |  |
Investments at fair value | $ 85 | $ 135 |  |
Number of Shares (in shares) | 309,208 | 309,208 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,965 | 4,959 |  |
Investments at fair value | $ 4,965 | $ 4,959 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,965 | 4,959 |  |
Investments at fair value | 4,965 | 4,959 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | 2,800 | 2,800 |  |
Investments at fair value | $ 1,281 | $ 1,281 |  |
Number of Shares (in shares) | 280,000 | 280,000 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,458 | 2,457 |  |
Investments at fair value | $ 2,458 | $ 2,457 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 3,500 | $ 3,500 |  |
Investments at cost | 3,490 | 3,489 |  |
Investments at fair value | 3,490 | 3,489 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 64 | 64 |  |
Investments at fair value | $ 138 | $ 135 |  |
Number of Shares (in shares) | 682 | 682 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,493 | 2,492 |  |
Investments at fair value | $ 2,493 | $ 2,492 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 1,500 | $ 1,500 |  |
Investments at cost | 1,496 | 1,495 |  |
Investments at fair value | 1,496 | 1,495 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 18 | 18 |  |
Investments at fair value | $ 42 | $ 42 |  |
Number of Shares (in shares) | 71,305 | 71,305 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 4 | $ 4 |  |
Investments at fair value | $ 193 | $ 193 |  |
Number of Shares (in shares) | 66,127 | 66,127 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 4.00% | 4.00% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,779 | 4,773 |  |
Investments at fair value | $ 4,779 | $ 4,773 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 4.00% | 4.00% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,470 | 2,467 |  |
Investments at fair value | 2,470 | 2,467 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 120 | 120 |  |
Investments at fair value | $ 211 | $ 105 |  |
Number of Shares (in shares) | 345,443 | 345,443 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 4.00% | 4.00% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,470 | 2,467 |  |
Investments at fair value | $ 2,470 | $ 2,467 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] |  |  |  |
Cash Rate | 14.00% |  |  |
Margin | 5.50% |  |  |
Floor | 14.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 3.00% |  |  |
Maturity Date | Apr. 01, 2029 |  |  |
Principal Amount | $ 2,500 |  |  |
Investments at cost | 2,464 |  |  |
Investments at fair value | $ 2,464 |  |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 14.00% | 14.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,899 | 4,860 |  |
Investments at fair value | $ 4,899 | $ 4,860 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 14.00% | 14.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,467 | 2,466 |  |
Investments at fair value | 2,467 | 2,466 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 98 | 98 |  |
Investments at fair value | $ 136 | $ 174 |  |
Number of Shares (in shares) | 161,215 | 161,215 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 14.00% | 14.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,467 | 2,466 |  |
Investments at fair value | $ 2,467 | $ 2,466 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 14.00% | 14.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,467 | 2,466 |  |
Investments at fair value | 2,467 | 2,466 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | E La Carte, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 60 | 60 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 147,361 | 147,361 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Everstream Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 70 | $ 70 |  |
Investments at fair value | $ 63 | $ 63 |  |
Number of Shares (in shares) | 350,000 | 350,000 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Revinate Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 44 | $ 44 |  |
Investments at fair value | $ 93 | $ 91 |  |
Number of Shares (in shares) | 682,034 | 682,034 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | SIGNiX, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 225 | $ 225 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 186,235 | 186,235 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Topia Mobility, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 138 | $ 138 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 3,049,607 | 3,049,607 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | xAd, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 177 | $ 177 |  |
Investments at fair value | $ 8 | $ 5 |  |
Number of Shares (in shares) | 4,343,348 | 4,343,348 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.75% | 15.75% |  |
Margin | 7.25% | 7.25% |  |
Floor | 10.50% | 10.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 3,033 | $ 3,383 |  |
Investments at cost | 3,009 | 3,356 |  |
Investments at fair value | 3,009 | 3,356 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 22 | 22 |  |
Investments at fair value | $ 28 | $ 27 |  |
Number of Shares (in shares) | 75,997 | 75,997 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025 |  |
Principal Amount | $ 1,417 | $ 1,667 |  |
Investments at cost | 1,408 | 1,656 |  |
Investments at fair value | $ 1,408 | $ 1,656 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.50% | 5.50% |  |
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025 |  |
Principal Amount | $ 1,417 | $ 1,583 |  |
Investments at cost | 1,408 | 1,573 |  |
Investments at fair value | 1,408 | 1,573 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 30 | 29 |  |
Investments at fair value | $ 124 | $ 122 |  |
Number of Shares (in shares) | 46,745 | 46,745 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,729 | 3,608 |  |
Investments at fair value | $ 3,729 | $ 3,608 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 1,250 | $ 1,250 |  |
Investments at cost | 1,243 | 1,242 |  |
Investments at fair value | 1,243 | 1,242 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 95 | 94 |  |
Investments at fair value | $ 259 | $ 250 |  |
Number of Shares (in shares) | 37,282 | 37,282 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,729 | 3,726 |  |
Investments at fair value | $ 3,729 | $ 3,726 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 1,250 | $ 1,250 |  |
Investments at cost | 1,243 | 1,242 |  |
Investments at fair value | $ 1,243 | $ 1,242 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,729 | 3,726 |  |
Investments at fair value | $ 3,729 | $ 3,726 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 1,250 | $ 1,250 |  |
Investments at cost | 1,243 | 1,242 |  |
Investments at fair value | $ 1,243 | $ 1,242 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,716 | 3,712 |  |
Investments at fair value | $ 3,716 | $ 3,712 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,716 | 3,712 |  |
Investments at fair value | $ 3,716 | $ 3,712 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,708 | 3,706 |  |
Investments at fair value | $ 3,708 | $ 3,706 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2028 | Jul. 01, 2028 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,709 | 3,707 |  |
Investments at fair value | $ 3,709 | $ 3,707 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 11.25% | 11.25% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2028 | Jul. 01, 2028 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,709 | 3,707 |  |
Investments at fair value | 3,709 | 3,707 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 93 | 93 |  |
Investments at fair value | $ 3 | $ 0 |  |
Number of Shares (in shares) | 20,000 | 20,000 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Aterian, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 195 | $ 195 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 6,140 | 76,923 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Caastle, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 68 | $ 65 |  |
Investments at fair value | $ 2,167 | $ 1,055 |  |
Number of Shares (in shares) | 268,591 | 268,591 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | CZV, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 81 | $ 81 |  |
Investments at fair value | $ 73 | $ 71 |  |
Number of Shares (in shares) | 65,569 | 65,569 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 5.00% | 5.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027 |  |
Principal Amount | $ 2,000 | $ 2,000 |  |
Investments at cost | 1,505 | 1,421 |  |
Investments at fair value | $ 1,505 | $ 1,421 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 5.00% | 5.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027 |  |
Principal Amount | $ 3,000 | $ 3,000 |  |
Investments at cost | 2,258 | 2,131 |  |
Investments at fair value | 2,258 | 2,131 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 2,947 | 2,947 |  |
Investments at fair value | $ 2,260 | $ 2,259 |  |
Number of Shares (in shares) | 1,312,500 | 1,312,500 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 10.50% | 10.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 7.78% | 7.78% |  |
Maturity Date | Feb. 01, 2028 | Feb. 01, 2028 |  |
Principal Amount | $ 2,813 | $ 2,813 |  |
Investments at cost | 2,813 | 2,813 |  |
Investments at fair value | $ 2,813 | $ 2,813 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 10.50% | 10.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 7.78% | 7.78% |  |
Maturity Date | Feb. 01, 2028 | Feb. 01, 2028 |  |
Principal Amount | $ 2,813 | $ 2,813 |  |
Investments at cost | 2,813 | 2,813 |  |
Investments at fair value | $ 2,813 | $ 2,813 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025 |  |
Principal Amount | $ 3,000 | $ 3,667 |  |
Investments at cost | 2,986 | 3,647 |  |
Investments at fair value | $ 2,986 | $ 3,647 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025 |  |
Principal Amount | $ 1,500 | $ 1,833 |  |
Investments at cost | 1,493 | 1,824 |  |
Investments at fair value | 1,493 | 1,824 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 29 | 29 |  |
Investments at fair value | $ 58 | $ 56 |  |
Number of Shares (in shares) | 250 | 250 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Getaround, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 253 | $ 253 |  |
Investments at fair value | $ 27 | $ 20 |  |
Number of Shares (in shares) | 87,082 | 87,082 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 5,744 | $ 5,752 |  |
Investments at cost | 5,744 | 5,752 |  |
Investments at fair value | $ 5,014 | $ 5,018 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 2,298 | $ 2,301 |  |
Investments at cost | 2,298 | 2,301 |  |
Investments at fair value | 2,006 | 2,007 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 188 | 188 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 12,618 | 12,618 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 9 | $ 9 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 1,224,752 | 1,224,752 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 2,872 | $ 2,876 |  |
Investments at cost | 2,872 | 2,876 |  |
Investments at fair value | 2,507 | 2,509 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | 89 | 89 |  |
Investments at fair value | $ 0 | $ 89 |  |
Number of Shares (in shares) | 2,688,971 | 2,688,971 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 3,446 | $ 3,451 |  |
Investments at cost | 3,446 | 3,451 |  |
Investments at fair value | $ 3,009 | $ 3,011 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 2,872 | $ 2,876 |  |
Investments at cost | 2,872 | 2,876 |  |
Investments at fair value | $ 2,507 | $ 2,510 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 2,872 | $ 2,876 |  |
Investments at cost | 2,872 | 2,876 |  |
Investments at fair value | $ 2,507 | $ 2,510 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 5,744 | $ 5,752 |  |
Investments at cost | 5,744 | 5,752 |  |
Investments at fair value | $ 5,014 | $ 5,018 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 2,872 | $ 2,876 |  |
Investments at cost | 2,872 | 2,876 |  |
Investments at fair value | 2,507 | 2,510 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | SnagAJob.com, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 10 | 9 |  |
Investments at fair value | $ 80 | $ 83 |  |
Number of Shares (in shares) | 82,974 | 82,974 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Lyrical Foods, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 1.00% | 1.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,590 | 2,591 |  |
Investments at fair value | $ 2,435 | $ 2,429 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.75% | 14.75% |  |
Margin | 6.25% | 6.25% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,424 | 2,416 |  |
Investments at fair value | $ 2,424 | $ 2,416 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.75% | 14.75% |  |
Margin | 6.25% | 6.25% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jul. 01, 2028 | Jul. 01, 2028 |  |
Principal Amount | $ 1,875 | $ 1,875 |  |
Investments at cost | 1,791 | 1,787 |  |
Investments at fair value | 1,791 | 1,787 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 179 | 182 |  |
Investments at fair value | $ 145 | $ 145 |  |
Number of Shares (in shares) | 11,550 | 11,550 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 57 | $ 57 |  |
Investments at fair value | $ 593 | $ 591 |  |
Number of Shares (in shares) | 553,778 | 553,778 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Quip NYC Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 325 | $ 325 |  |
Investments at fair value | $ 232 | $ 533 |  |
Number of Shares (in shares) | 6,191 | 6,191 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 16.25% | 16.25% |  |
Margin | 7.75% | 7.75% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | May 01, 2027 | May 01, 2027 |  |
Principal Amount | $ 1,254 | $ 1,204 |  |
Investments at cost | 1,086 | 1,086 |  |
Investments at fair value | $ 570 | $ 872 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 16.25% | 16.25% |  |
Margin | 7.75% | 7.75% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | May 01, 2027 | May 01, 2027 |  |
Principal Amount | $ 627 | $ 602 |  |
Investments at cost | 543 | 543 |  |
Investments at fair value | 285 | 436 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 32 | 32 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 171,081 | 171,081 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 16.25% | 16.25% |  |
Margin | 7.75% | 7.75% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | May 01, 2027 | May 01, 2027 |  |
Principal Amount | $ 627 | $ 602 |  |
Investments at cost | 543 | 543 |  |
Investments at fair value | 285 | 436 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Updater, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 34 | 34 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 114,659 | 114,659 |  |
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | $ 5,505 | $ 5,335 |  |
Investments at fair value | $ 5,143 | $ 4,969 |  |
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.78% | 1.85% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 3,658 | $ 3,547 |  |
Investments at cost | 3,698 | 3,585 |  |
Investments at fair value | $ 3,455 | $ 3,339 |  |
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.78% | 1.85% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 1,829 | $ 1,773 |  |
Investments at cost | 1,807 | 1,750 |  |
Investments at fair value | 1,688 | 1,630 |  |
Other Sustainability Sector [Member] |  |  |  |
Investments at cost | 100,854 | 98,906 |  |
Investments at fair value | 71,060 | 80,370 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost | 1,001 | 999 |  |
Investments at fair value | $ 559 | $ 542 |  |
Number of Shares (in shares) |  |  |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.33% | 4.33% |  |
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,695 | 3,685 |  |
Investments at fair value | $ 3,695 | $ 3,685 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.33% | 4.33% |  |
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,695 | 3,685 |  |
Investments at fair value | 3,695 | 3,685 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 81 | 81 |  |
Investments at fair value | $ 74 | $ 72 |  |
Number of Shares (in shares) | 400,000 | 400,000 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | LiquiGlide, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 39 |  |
Investments at fair value |  | $ 50 |  |
Number of Shares (in shares) |  | 61,359 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | LiquiGlide, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 39 |  |  |
Investments at fair value | $ 51 |  |  |
Number of Shares (in shares) | 61,359 |  |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 8,759 | $ 8,425 |  |
Investments at cost | 8,431 | 8,353 |  |
Investments at fair value | $ 2,477 | $ 4,549 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 8,759 | $ 8,425 |  |
Investments at cost | 8,229 | 8,229 |  |
Investments at fair value | 2,418 | 4,481 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 490 | 490 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 215,171 | 215,171 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 8,759 | $ 8,425 |  |
Investments at cost | 8,229 | 8,229 |  |
Investments at fair value | $ 2,418 | $ 4,481 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 5,840 | $ 5,617 |  |
Investments at cost | 5,480 | 5,480 |  |
Investments at fair value | $ 1,610 | $ 2,984 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 5,840 | $ 5,617 |  |
Investments at cost | 5,480 | 5,480 |  |
Investments at fair value | $ 1,610 | $ 2,984 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 764 | $ 735 |  |
Investments at cost | 726 | 726 |  |
Investments at fair value | $ 213 | $ 395 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 609 | $ 586 |  |
Investments at cost | 578 | 578 |  |
Investments at fair value | $ 170 | $ 315 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 304 | $ 292 |  |
Investments at cost | 288 | 288 |  |
Investments at fair value | $ 85 | $ 157 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 301 | $ 290 |  |
Investments at cost | 286 | 286 |  |
Investments at fair value | $ 84 | $ 156 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 181 | $ 174 |  |
Investments at cost | 172 | 172 |  |
Investments at fair value | $ 50 | $ 93 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 833 | $ 802 |  |
Investments at cost | 791 | 791 |  |
Investments at fair value | $ 232 | $ 431 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Fixed Index One [Member] |  |  |  |
Cash Rate | 15.50% |  |  |
Margin | 0.00% |  |  |
Floor | 0.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 0.00% |  |  |
Maturity Date | Apr. 30, 2024 |  |  |
Principal Amount | $ 418 |  |  |
Investments at cost | 397 |  |  |
Investments at fair value | $ 117 |  |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |
Cash Rate | 15.50% |  |  |
Margin | 0.00% |  |  |
Floor | 0.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 0.00% |  |  |
Maturity Date | Apr. 30, 2024 |  |  |
Principal Amount | $ 552 |  |  |
Investments at cost | 502 |  |  |
Investments at fair value | $ 147 |  |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Fixed Index Three [Member] |  |  |  |
Cash Rate | 15.50% |  |  |
Margin | 0.00% |  |  |
Floor | 0.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 0.00% |  |  |
Maturity Date | Apr. 30, 2024 |  |  |
Principal Amount | $ 411 |  |  |
Investments at cost | 405 |  |  |
Investments at fair value | $ 119 |  |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Twelve [Member] |  |  |  |
Cash Rate | 15.50% | 15.50% |  |
Margin | 7.00% | 7.00% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Mar. 31, 2024 | Mar. 31, 2024 |  |
Principal Amount | $ 1,134 | $ 1,091 |  |
Investments at cost | 1,083 | 1,083 |  |
Investments at fair value | $ 318 | $ 590 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Fixed Index Four [Member] |  |  |  |
Cash Rate | 15.50% |  |  |
Margin | 0.00% |  |  |
Floor | 0.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 0.00% |  |  |
Maturity Date | Apr. 30, 2024 |  |  |
Principal Amount | $ 487 |  |  |
Investments at cost | 486 |  |  |
Investments at fair value | $ 143 |  |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,967 | 4,959 |  |
Investments at fair value | $ 4,967 | $ 4,959 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,483 | 2,479 |  |
Investments at fair value | 2,483 | 2,479 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 216 | 214 |  |
Investments at fair value | $ 350 | $ 340 |  |
Number of Shares (in shares) | 681 | 681 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,964 | 4,956 |  |
Investments at fair value | $ 4,964 | $ 4,956 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,482 | 2,478 |  |
Investments at fair value | $ 2,482 | $ 2,478 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,942 | 4,934 |  |
Investments at fair value | $ 4,942 | $ 4,934 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,471 | 2,467 |  |
Investments at fair value | $ 2,471 | $ 2,467 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,697 | 3,694 |  |
Investments at fair value | $ 3,697 | $ 3,694 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,697 | 3,694 |  |
Investments at fair value | 3,697 | 3,694 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 175 | 175 |  |
Investments at fair value | $ 84 | $ 80 |  |
Number of Shares (in shares) | 46,311 | 46,311 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 7,500 | $ 7,500 |  |
Investments at cost | 7,386 | 7,379 |  |
Investments at fair value | $ 7,386 | $ 7,379 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,693 | 3,690 |  |
Investments at fair value | $ 3,693 | $ 3,690 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750 | $ 3,750 |  |
Investments at cost | 3,693 | 3,690 |  |
Investments at fair value | $ 3,693 | $ 3,690 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.00% | 2.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 4,500 | $ 4,500 |  |
Investments at cost | 4,448 | 4,446 |  |
Investments at fair value | $ 4,448 | $ 4,446 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.00% | 2.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 2,000 | $ 2,000 |  |
Investments at cost | 1,977 | 1,976 |  |
Investments at fair value | 1,977 | 1,976 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 111 | 111 |  |
Investments at fair value | $ 8 | $ 13 |  |
Number of Shares (in shares) | 5,205 | 5,205 |  |
Diagnostics Sector [Member] |  |  |  |
Investments at cost | $ 19,759 | $ 19,735 |  |
Investments at fair value | $ 19,729 | $ 19,701 |  |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,487 | 2,484 |  |
Investments at fair value | $ 2,487 | $ 2,484 |  |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 2,500 | $ 2,500 |  |
Investments at cost | 2,487 | 2,484 |  |
Investments at fair value | 2,487 | 2,484 |  |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 47 | 46 |  |
Investments at fair value | $ 12 | $ 12 |  |
Number of Shares (in shares) | 171,370 | 171,370 |  |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 14.50% | 14.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,973 | 4,968 |  |
Investments at fair value | $ 4,973 | $ 4,968 |  |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.50% | 11.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,639 | 4,633 |  |
Investments at fair value | $ 4,639 | $ 4,633 |  |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.50% | 11.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,890 | 4,884 |  |
Investments at fair value | 4,890 | 4,884 |  |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 70 | 70 |  |
Investments at fair value | $ 70 | $ 70 |  |
Number of Shares (in shares) | 32,244 | 32,244 |  |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 166 | $ 166 |  |
Investments at fair value | $ 171 | $ 166 |  |
Number of Shares (in shares) | 184,253 | 184,253 |  |
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | $ 264,468 | $ 275,026 |  |
Investments at fair value | 257,817 | 269,790 |  |
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost | 9,741 | 9,733 |  |
Investments at fair value | 15,275 | 14,506 |  |
Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member] |  |  |  |
Investments at cost | 4,060 | 3,311 |  |
Investments at fair value | 2,656 | 3,024 |  |
Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 2,060 | 2,061 |  |
Investments at fair value | $ 659 | $ 2,165 |  |
Number of Shares (in shares) | 2,278,272 | 2,278,272 |  |
Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 2,000 | $ 1,250 |  |
Investments at fair value | $ 1,997 | $ 859 |  |
Number of Shares (in shares) | 4,458,452 | 3,124,448 |  |
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | $ 256,228 | $ 249,642 |  |
Investments at fair value | 254,853 | 244,815 |  |
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Other Investments [Member] |  |  |  |
Investments at cost | 8,381 | 1,200 |  |
Investments at fair value | 3,347 | 200 |  |
Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | 23,564 | 23,551 |  |
Investments at fair value |  | 1,000 |  |
Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member] |  |  |  |
Investments at cost | 5,000 | 5,000 |  |
Investments at fair value | $ 0 | $ 132 |  |
Number of Shares (in shares) |  |  |  |
Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] |  |  |  |
Investments at cost | $ 5,463 | $ 5,782 |  |
Investments at fair value | 5,845 | 6,230 |  |
Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Other Investments [Member] |  |  |  |
Investments at cost | 5,463 | 5,782 |  |
Investments at fair value | 5,845 | 6,230 |  |
Other Healthcare Sector [Member] |  |  |  |
Investments at cost | 102 | 102 |  |
Investments at fair value | 949 | 1,366 |  |
Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kate Farms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 102 | 102 |  |
Investments at fair value | $ 949 | $ 1,366 |  |
Number of Shares (in shares) | 82,965 | 82,965 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | $ 69,882 | $ 69,770 |  |
Investments at fair value | 69,882 | 69,770 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost | 967 | 966 |  |
Investments at fair value | 1,492 | 1,871 |  |
Data Storage Sector [Member] |  |  |  |
Investments at cost | 416 | 417 |  |
Investments at fair value | 426 | 418 |  |
Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | CPG Beyond, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 241 | 242 |  |
Investments at fair value | $ 298 | $ 294 |  |
Number of Shares (in shares) | 500,000 | 500,000 |  |
Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Silk, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 175 | $ 175 |  |
Investments at fair value | $ 128 | $ 124 |  |
Number of Shares (in shares) | 394,110 | 394,110 |  |
Internet and Media Sector [Member] |  |  |  |
Investments at cost | $ 328 | $ 329 |  |
Investments at fair value | 1,592 | 1,582 |  |
Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Global Worldwide LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 74 | 75 |  |
Investments at fair value | $ 63 | $ 63 |  |
Number of Shares (in shares) | 245,810 | 245,810 |  |
Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Rocket Lawyer Incorporated [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 92 | $ 92 |  |
Investments at fair value | $ 323 | $ 318 |  |
Number of Shares (in shares) | 261,721 | 261,721 |  |
Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Skillshare, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 162 | $ 162 |  |
Investments at fair value | $ 1,206 | $ 1,201 |  |
Number of Shares (in shares) | 139,074 | 139,074 |  |
Networking Sector [Member] |  |  |  |
Investments at cost | $ 3,231 | $ 5,451 |  |
Investments at fair value | $ 3,091 | $ 5,297 |  |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.75% | 14.75% |  |
Margin | 6.25% | 6.25% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024 |  |
Principal Amount | $ 833 | $ 1,500 |  |
Investments at cost | 822 | 1,481 |  |
Investments at fair value | $ 822 | $ 1,481 |  |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.75% | 14.75% |  |
Margin | 6.25% | 6.25% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024 |  |
Principal Amount | $ 833 | $ 1,500 |  |
Investments at cost | 822 | 1,481 |  |
Investments at fair value | 822 | 1,481 |  |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 364 | 364 |  |
Investments at fair value | $ 224 | $ 210 |  |
Number of Shares (in shares) | 344,102 | 344,102 |  |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 14.75% | 14.75% |  |
Margin | 6.25% | 6.25% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024 |  |
Principal Amount | $ 417 | $ 750 |  |
Investments at cost | 410 | 740 |  |
Investments at fair value | $ 410 | $ 740 |  |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 14.75% | 14.75% |  |
Margin | 6.25% | 6.25% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024 |  |
Principal Amount | $ 417 | $ 667 |  |
Investments at cost | 410 | 656 |  |
Investments at fair value | $ 410 | $ 656 |  |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 14.75% | 14.75% |  |
Margin | 6.25% | 6.25% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024 |  |
Principal Amount | $ 417 | $ 750 |  |
Investments at cost | 403 | 729 |  |
Investments at fair value | 403 | 729 |  |
Power Management Sector [Member] |  |  |  |
Investments at cost | 1,585 | 1,585 |  |
Investments at fair value | 2,700 | 2,700 |  |
Power Management Sector [Member] | Investment, Unaffiliated Issuer [Member] | Halio, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 1,585 | 1,585 |  |
Investments at fair value | $ 2,700 | $ 2,700 |  |
Number of Shares (in shares) | 38,241,466 | 38,241,466 |  |
Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost | $ 4,802 | $ 4,702 |  |
Investments at fair value | 6,602 | 7,675 |  |
Semiconductor Sector [Member] |  |  |  |
Investments at cost | 45 | 45 |  |
Investments at fair value | 0 | 0 |  |
Semiconductor Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalanche Technology, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 45 | 45 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 5,938 | 5,938 |  |
Software, Healthcare Information and Service [Member] |  |  |  |
Investments at cost | $ 50,988 | $ 50,899 |  |
Investments at fair value | $ 50,696 | $ 50,574 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 7,000 | $ 7,000 |  |
Investments at cost | 6,727 | 6,684 |  |
Investments at fair value | $ 6,727 | $ 6,684 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 3,500 | $ 3,500 |  |
Investments at cost | 3,466 | 3,463 |  |
Investments at fair value | $ 3,466 | $ 3,463 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 3,500 | $ 3,500 |  |
Investments at cost | 3,466 | 3,463 |  |
Investments at fair value | $ 3,466 | $ 3,463 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 2,750 | $ 2,750 |  |
Investments at cost | 2,713 | 2,710 |  |
Investments at fair value | $ 2,713 | $ 2,710 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2027 | Oct. 01, 2027 |  |
Principal Amount | $ 10,000 | $ 10,000 |  |
Investments at cost | 9,666 | 9,656 |  |
Investments at fair value | $ 9,666 | $ 9,656 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2027 | Oct. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,930 | 4,925 |  |
Investments at fair value | $ 4,930 | $ 4,925 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2027 | Oct. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,930 | 4,925 |  |
Investments at fair value | $ 4,930 | $ 4,925 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2027 | Oct. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,930 | 4,925 |  |
Investments at fair value | $ 4,930 | $ 4,925 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,654 | 4,648 |  |
Investments at fair value | $ 4,654 | $ 4,648 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 5,000 | $ 5,000 |  |
Investments at cost | 4,924 | 4,918 |  |
Investments at fair value | 4,924 | 4,918 |  |
Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | 99,853 | 97,907 |  |
Investments at fair value | $ 70,501 | $ 79,828 |  |

X
- Definition The ceiling rate of the investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedCeilingRate
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The end of term payment rate (ETP) on investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maturity date of investment, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-2 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AuleaMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerControlledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HIMVLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TallacTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ZetrozIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CandesantBiomedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CVRXIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MicroTransponderIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_Engage3LLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MirantisIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ReputationInstituteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexElevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AterianIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CZVIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NewAerofarmsIncAssigneeOfAerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwelveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ParseBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_HealthcareInformationAndServicesSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DataStorageSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CPGBeyondIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_InternetAndMediaSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_PowerManagementSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HalioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SemiconductorSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareHealthcareInformationAndServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |